Using Citizen Science to organize biomedical knowledge
•Download as PPTX, PDF•
4 likes•3,594 views
Talk on "Using Citizen Science to organize biomedical knowledge" given March 5, 2015 at the Future of Genomic Medicine conference in La Jolla, CA
Recommended
Recommended
More Related Content
What's hot
What's hot (20)
Similar to Using Citizen Science to organize biomedical knowledge
Similar to Using Citizen Science to organize biomedical knowledge (20)
More from Andrew Su
More from Andrew Su (20)
Recently uploaded
Recently uploaded (20)
Using Citizen Science to organize biomedical knowledge
- 1. Using Citizen Science to organize biomedical knowledge Andrew Su, Ph.D. @andrewsu asu@scripps.edu http://sulab.org March 5, 2015 Future of Genomic Medicine Slides posted at slideshare.net/andrewsu
- 3. The biomedical literature is growing fast… 3 0 200,000 400,000 600,000 800,000 1,000,000 1,200,000 1983 1988 1993 1998 2003 2008 2013 Number of new PubMed-indexed articles
- 4. … but it is very hard to query and compute 4
- 5. … but it is very hard to query and compute 5 Imatinib Crizotinib Erlotinib Gefitinib Sorafenib Lapatinib Dasatinib … Acute myeloid leukemia Acute lymphoblastic leukemia Chronic myelogenous leukemia Chronic lymphocytic leukemia Hodgkin lymphoma Non-Hodgkin lymphoma Myeloma … AND
- 6. 6 Pathways Diseases Proteins Variants Genes Drugs Goal: Assemble a network of biomedical knowledge that is comprehensive, current, computable and traceable.
- 7. Information Extraction 7 1. Identify high level concepts in text 2. Identify relationships between concepts
- 8. 8 Doğan and Lu. Proceedings of the 2012 Workshop on BioNLP, 2012, 91-9. NCBI Disease Corpus 593 PubMed abstracts 12 expert annotators (2 per document) 6,900 “disease concept” mentions
- 9. Question: Can a group of non-scientists collectively perform concept recognition in biomedical texts? 9
- 10. Amazon Mechanical Turk (AMT) 10 Requester Amazon Workers 1. Create tasks 2. Execute 3. Aggregate
- 11. Experimental design Task: Identify the “disease concepts” in the 593 abstracts from the NCBI disease corpus – $0.06 per Human Intelligence Task (HIT) – HIT = annotate one abstract from PubMed – 15 workers annotate each abstract 11
- 12. Comparison to gold standard 12 K = 6 F score = 0.87 • 593 documents • 15 users / doc • 9 days • 145 workers • $630.96 Precision Recall
- 13. Comparisons to text-mining algorithms 13 Fscore Text-mining AMT experiments
- 14. Comparisons to human annotators 14 Average level of agreement between expert annotators (stage 1) F = 0.76
- 15. Comparisons to human annotators 15 F = 0.76 F = 0.87 Average level of agreement between expert annotators (stage 2)
- 16. Does Mechanical Turk scale? 16 1,000,000 articles per year 10 annotators / article 4 tasks / doc $0.06 / task $ 2,400,000 / year
- 17. Question: Can a group of non-scientists collectively perform concept recognition in biomedical texts ? 17 and will they do it for free? ^
- 19. Mark2Cure Campaign #0 • Goal: replicate the NCBI disease corpus – 593 documents, 15x redundancy • Launched Jan 19, 2015 • Completed Feb 16, 2015 19 – 4 weeks – 10,275 document annotation events – 212 unique users
- 20. 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 Comparison to gold standard 20 k = 6 F score = 0.84 PrecisionRecall Voting threshold Total cost: $0
- 21. Does Citizen Science scale? 21 1,000,000 articles * 10 AE / article 15,828 volunteers needed 10,275 AE * 365 days 212 annotators* 28 days AE = Annotation events = Number of annotation events per year Number of annotation events per year per volunteer
- 22. Does Citizen Science scale? 22 15,828 volunteers needed 175,000 volunteers 300,000 volunteers 37,000 volunteers 1,000,000 volunteers
- 23. Annotating the relationships 23 This molecule inhibits the growth of a broad panel of cancer cell lines, and is particularly efficacious in leukemia cells, including orthotopic leukemia preclinical models as well as in ex vivo acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL) patient tumor samples. Thus, inhibition of CDK9 may represent an interesting approach as a cancer therapeutic target especially in hematologic malignancies. therapeutic target subject predicate object GENE DISEASE
- 25. 25 Cyrus Afrasiabi Sebastian Burgstaller Ramya Gamini Louis Gioia Salvatore Loguercio Adam Mark Erick Scott Greg Stupp Andra Waagmeester Kevin Xin Other group members Contact http://sulab.org asu@scripps.edu @andrewsu +Andrew Su Mark2Cure Ben Good Max Nanis Ginger Tsueng Chunlei Wu All Mark2Curators! Funding and Support BioGPS: GM83924 Gene Wiki: GM089820 BD2K Center of Excellence: GM114833 Icon credits (Noun Project, Wikimedia Commons): Zach VanDeHey, hunotika, Viktorvoigt, Alberto Rojas, Lloyd Humphreys Matt and Cristina Might NGLY1 community
- 26. Why do I Mark2Cure? 26 I am retired, have a doctorate in medical humanities, and have two children with Gaucher disease. I am just looking for some way to put my education to use. My 4 year old daughter Phoebe is living with and battling rare disease. I have Ehlers Danlos Syndrome. I hope to help people learn about this painful and debilitating disorder, so that others like me can receive more effective medical care. Take part in something that helps humanity. I Mark2Cure in memory of my son Mike who had type 1 diabetes. Studied biology in college and I really miss it! In memory of my daughter who had Cystic Fibrosis To give back